Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 326 followers
Latest posts
Last updated about 2 hours ago
Charles River to close cell therapy CDMO site, lay off 20 staffers
about 2 hours ago
Charles River Laboratories is continuing its run of layoffs by announcing the...
FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases
about 3 hours ago
As the first CAR-T treatment for an autoimmune disease draws ever closer...
Pfizer CEO says pipeline pruning is mostly finished after 6 more early-stage culls, $4.4B in impairment charges
about 3 hours ago
Pfizer has pumped the brakes on six early-stage assets, including three being...
Fledgling biotech Exxel plans $13M IPO to succeed where other FAAH inhibitors have failed
about 3 hours ago
Exxel Pharma is eyeing a listing on the NYSE American to fund...
Pfizer's $10B monthly GLP-1 bet generates competitive weight loss in phase 2b
about 6 hours ago
Patients in a phase 2b trial kept losing weight after switching to...
Quest launches residual disease blood test for multiple myeloma
about 8 hours ago
Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple...
NMD flunks rare disease trial, but flexes secondary data to accelerate program
about 10 hours ago
A phase 2a trial of NMD Pharma’s rare disease prospect ignaseclant has...
Novo’s CagriSema tops semaglutide in ph. 3 diabetes study
about 24 hours ago
Novo Nordisk’s GLP-1/amylin combo has topped blockbuster semaglutide in a phase 3...
GSK plans to lay off up to 350 R&D workers across US, UK
1 day ago
GSK is trimming its R&D team, a move that is expected to...
Thermo Fisher trims Massachusetts headcount with Franklin site closure
1 day ago
Thermo Fisher is continuing its recent layoff spree with a fresh round...
GSK gives back rights to Wave's genetic disease RNA editor
1 day ago
Wave Life Sciences has the fate of its lead RNA editing candidate...
Daiichi stops internal development of next-wave ADC as key Datroway readout delayed again
1 day ago
Daiichi Sankyo’s development of ADCs continues to hit turbulence. The company has...